{"product_id":"glyxambi-25-5mg","title":"Glyxambi 25\/5mg","description":"\u003cp\u003e\u003cstrong\u003eGlyxambi (Empagliflozin + Linagliptin): Comprehensive Guide\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003ch3\u003eWhat is Glyxambi?\u003c\/h3\u003e\r\n\u003cp\u003e\u003cstrong\u003eGlyxambi\u003c\/strong\u003e is an oral combination medication used for the management of \u003cstrong\u003eType 2 diabetes mellitus\u003c\/strong\u003e. It contains two active ingredients that work synergistically to improve glycemic control:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eEmpagliflozin\u003c\/strong\u003e – a member of the \u003cstrong\u003e\u003ca target=\"_new\" rel=\"noopener\"\u003eSGLT2 (Sodium-Glucose Co-Transporter-2) inhibitors\u003c\/a\u003e\u003c\/strong\u003e class that reduces blood sugar by preventing renal glucose reabsorption and increasing urinary glucose excretion.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eLinagliptin\u003c\/strong\u003e – a \u003cstrong\u003e\u003ca target=\"_new\" rel=\"noopener\"\u003eDPP-4 (Dipeptidyl Peptidase-4) inhibitor\u003c\/a\u003e\u003c\/strong\u003e that enhances the body's incretin system, leading to increased insulin secretion and decreased glucagon production in a glucose-dependent manner.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003eManufactured by \u003cstrong\u003eBoehringer Ingelheim\u003c\/strong\u003e and \u003cstrong\u003eEli Lilly and Company\u003c\/strong\u003e, Glyxambi is \u003cstrong\u003eClinically Approved Pharmaceuticals\u003c\/strong\u003e and is indicated for patients who need improved glycemic control beyond what is achieved with diet and exercise alone.\u003c\/p\u003e\r\n\u003cp\u003e\u003cem\u003eReferences: \u003ca target=\"_new\" rel=\"noopener\"\u003eFDA Glyxambi Prescribing Information\u003c\/a\u003e, \u003ca target=\"_new\" rel=\"noopener\"\u003eDrugs.com: Empagliflozin\u003c\/a\u003e, \u003ca target=\"_new\" rel=\"noopener\"\u003eDrugs.com: Linagliptin\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhat are the benefits of Glyxambi for managing Type 2 Diabetes?\u003c\/h3\u003e\r\n\u003ch4\u003e1. \u003cstrong\u003eEnhanced Glycemic Control\u003c\/strong\u003e\n\u003c\/h4\u003e\r\n\u003cp\u003eClinical studies have demonstrated that Glyxambi significantly reduces \u003cstrong\u003eHbA1c levels\u003c\/strong\u003e compared to monotherapy. The dual mechanism of action helps patients achieve better glycemic control by addressing hyperglycemia from both renal and pancreatic pathways.\u003cbr\u003e\u003cem\u003eReference: \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/\" target=\"_new\" rel=\"noopener\"\u003eClinical Trial Data on SGLT2 and DPP-4 Inhibitors\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\u003ch4\u003e2. \u003cstrong\u003eDual Mechanism of Action\u003c\/strong\u003e\n\u003c\/h4\u003e\r\n\u003cp\u003eBy combining an \u003cstrong\u003eSGLT2 inhibitor\u003c\/strong\u003e with a \u003cstrong\u003eDPP-4 inhibitor\u003c\/strong\u003e, Glyxambi targets different aspects of diabetes pathophysiology:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eEmpagliflozin\u003c\/strong\u003e lowers blood glucose by promoting its excretion.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eLinagliptin\u003c\/strong\u003e enhances endogenous incretin activity, improving insulin secretion and reducing glucagon levels.\u003cbr\u003e\u003cem\u003eReference: \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/\" target=\"_new\" rel=\"noopener\"\u003eMechanism of Action - PubMed\u003c\/a\u003e\u003c\/em\u003e\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e3. \u003cstrong\u003eWeight Management\u003c\/strong\u003e\n\u003c\/h4\u003e\r\n\u003cp\u003eEmpagliflozin is associated with \u003cstrong\u003emodest weight loss\u003c\/strong\u003e due to caloric loss via glycosuria, while linagliptin is generally weight neutral. This combination is particularly beneficial for overweight individuals with Type 2 diabetes.\u003c\/p\u003e\r\n\u003ch4\u003e4. \u003cstrong\u003eCardiovascular and Renal Benefits\u003c\/strong\u003e\n\u003c\/h4\u003e\r\n\u003cp\u003eEmpagliflozin has shown to reduce cardiovascular mortality and slow the progression of renal disease, as evidenced in the landmark \u003cstrong\u003e\u003ca target=\"_new\" rel=\"noopener\"\u003eEMPA-REG OUTCOME trial\u003c\/a\u003e\u003c\/strong\u003e. These benefits extend to patients using Glyxambi, making it a valuable option for those at risk for heart and kidney complications.\u003c\/p\u003e\r\n\u003ch4\u003e5. \u003cstrong\u003eConvenience and Improved Compliance\u003c\/strong\u003e\n\u003c\/h4\u003e\r\n\u003cp\u003eOffering the benefits of two therapies in a single, once-daily tablet simplifies the treatment regimen, which can lead to better patient adherence and improved overall outcomes.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhat are the side effects of Glyxambi?\u003c\/h3\u003e\r\n\u003ch4\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eGenital Infections:\u003c\/strong\u003e Increased risk due to empagliflozin’s promotion of glycosuria.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eUrinary Tract Infections (UTIs):\u003c\/strong\u003e Symptoms may include burning during urination.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eRespiratory Infections:\u003c\/strong\u003e Upper respiratory tract infections have been reported with linagliptin.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eHypoglycemia:\u003c\/strong\u003e Particularly when used alongside other glucose-lowering medications such as insulin or sulfonylureas.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cstrong\u003eRare but Serious Side Effects:\u003c\/strong\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eDiabetic Ketoacidosis (DKA):\u003c\/strong\u003e Although rare, there is a risk associated with SGLT2 inhibitors.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eAcute Kidney Injury:\u003c\/strong\u003e Caution is advised in patients with pre-existing renal impairment.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003ePancreatitis:\u003c\/strong\u003e A potential risk with DPP-4 inhibitors, warranting prompt medical attention if suspected.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cem\u003eReference: \u003ca target=\"_new\" rel=\"noopener\"\u003eFDA Glyxambi Safety Information\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhat should I know before taking Glyxambi?\u003c\/h3\u003e\r\n\u003ch4\u003e\u003cstrong\u003e1. Contraindications and Precautions:\u003c\/strong\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eNot for Type 1 Diabetes:\u003c\/strong\u003e Glyxambi is not indicated for patients with Type 1 diabetes or those with a history of diabetic ketoacidosis.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eRenal Impairment:\u003c\/strong\u003e It is contraindicated in patients with severe renal impairment (as defined by specific eGFR thresholds) or those on dialysis.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003ePancreatitis History:\u003c\/strong\u003e Patients with a history of pancreatitis should exercise caution.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cstrong\u003e2. Drug Interactions:\u003c\/strong\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eConcomitant use with other \u003cstrong\u003eblood glucose-lowering agents\u003c\/strong\u003e (such as insulin or sulfonylureas) may increase the risk of hypoglycemia.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eDrugs affecting renal function\u003c\/strong\u003e should be used with caution in patients taking Glyxambi.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cstrong\u003e3. Pregnancy and Breastfeeding:\u003c\/strong\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eGlyxambi is generally \u003cstrong\u003enot recommended during pregnancy or breastfeeding\u003c\/strong\u003e. Consult your healthcare provider for alternative therapies.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cstrong\u003e4. Monitoring:\u003c\/strong\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eRegular monitoring of \u003cstrong\u003eblood glucose levels, renal function,\u003c\/strong\u003e and signs of infection is essential during treatment.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cem\u003eReference: \u003ca href=\"https:\/\/www.diabetes.org\/\" target=\"_new\" rel=\"noopener\"\u003eAmerican Diabetes Association Guidelines\u003c\/a\u003e, \u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\"\u003eFDA Safety Alerts\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhy is Glyxambi prescribed?\u003c\/h3\u003e\r\n\u003cp\u003eGlyxambi is prescribed to:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eImprove Glycemic Control:\u003c\/strong\u003e As an adjunct to diet and exercise in adults with Type 2 diabetes inadequately controlled by monotherapy.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eReduce Cardiovascular and Renal Risks:\u003c\/strong\u003e The empagliflozin component offers proven benefits in reducing cardiovascular mortality and slowing kidney disease progression.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eSimplify Treatment Regimens:\u003c\/strong\u003e Combining two effective therapies into one tablet can enhance adherence and overall patient outcomes.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhy choose Glyxambi over other combination treatments?\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eDual Action:\u003c\/strong\u003e The combination of an SGLT2 inhibitor (empagliflozin) and a DPP-4 inhibitor (linagliptin) provides a complementary approach to managing hyperglycemia.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eRobust Clinical Evidence:\u003c\/strong\u003e Glyxambi’s components are supported by extensive clinical trials demonstrating significant improvements in \u003cstrong\u003eHbA1c\u003c\/strong\u003e, weight management, and cardiovascular outcomes.\u003cbr\u003e\u003cem\u003eReference: \u003ca target=\"_new\" rel=\"noopener\"\u003eEMPA-REG OUTCOME Trial\u003c\/a\u003e\u003c\/em\u003e\n\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eConvenience:\u003c\/strong\u003e A single tablet regimen reduces pill burden and can lead to improved medication adherence.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eFavorable Safety Profile:\u003c\/strong\u003e When used as directed, Glyxambi offers an effective and well-tolerated option for many patients.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eHow does Glyxambi work in the body?\u003c\/h3\u003e\r\n\u003cp\u003e\u003cstrong\u003eEmpagliflozin:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eInhibits the \u003cstrong\u003eSGLT2 protein\u003c\/strong\u003e in the kidneys, preventing glucose reabsorption and promoting its excretion via urine, which leads to a reduction in blood sugar levels.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003e\u003cstrong\u003eLinagliptin:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003eInhibits \u003cstrong\u003eDPP-4\u003c\/strong\u003e, an enzyme that degrades incretin hormones. This results in prolonged incretin activity, enhancing insulin secretion and reducing glucagon levels in a glucose-dependent manner.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003eTogether, these mechanisms provide a \u003cstrong\u003ecomprehensive approach\u003c\/strong\u003e to managing Type 2 diabetes by targeting both renal and pancreatic pathways.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eHow should Glyxambi be taken (with or without food)?\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Glyxambi is taken orally once daily, with or without food. Taking it with food may help reduce gastrointestinal discomfort related to linagliptin.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eDosage:\u003c\/strong\u003e Follow your healthcare provider’s instructions regarding dosage. The typical fixed-dose combinations are designed to simplify the regimen.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003eTablet Integrity:\u003c\/strong\u003e Do not crush or split the tablet unless specifically advised by your healthcare provider.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhat are the available doses of Glyxambi?\u003c\/h3\u003e\r\n\u003cp\u003eGlyxambi is available in fixed-dose combinations, typically including:\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cstrong\u003eEmpagliflozin 10mg \/ Linagliptin 5mg\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cstrong\u003eEmpagliflozin 25mg \/ Linagliptin 5mg\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp\u003eThese formulations allow for tailored therapy based on the patient's glycemic control needs and overall health profile.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhere can I buy Glyxambi online safely?\u003c\/h3\u003e\r\n\u003cp\u003eTo ensure safety and authenticity, purchase \u003cstrong\u003eGlyxambi\u003c\/strong\u003e from reputable online pharmacies such as \u003ca href=\"https:\/\/www.waldrugmart.com\" target=\"_new\" rel=\"noopener\"\u003e\u003cstrong\u003eWaldrugmart\u003c\/strong\u003e\u003c\/a\u003e, which require a valid prescription, offer verified customer support, and provide secure shipping options.\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eWhere can I learn more about Glyxambi?\u003c\/h3\u003e\r\n\u003cp\u003eFor additional information and detailed prescribing guidelines, consult the following trusted sources:\u003c\/p\u003e\r\n\u003col\u003e\r\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"https:\/\/www.glyxambi.com\" target=\"_new\" rel=\"noopener\"\u003eOfficial Glyxambi Website\u003c\/a\u003e\u003c\/strong\u003e – Manufacturer’s information and patient resources.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\"\u003eFDA Medication Guide\u003c\/a\u003e\u003c\/strong\u003e – Regulatory-approved prescribing information.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"https:\/\/www.diabetes.org\/\" target=\"_new\" rel=\"noopener\"\u003eAmerican Diabetes Association (ADA)\u003c\/a\u003e\u003c\/strong\u003e – Educational resources on diabetes management.\u003c\/li\u003e\r\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/\" target=\"_new\" rel=\"noopener\"\u003ePubMed\u003c\/a\u003e\u003c\/strong\u003e – For peer-reviewed clinical research articles.\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003eFinal Thoughts\u003c\/h3\u003e\r\n\u003cp\u003e\u003cstrong\u003eGlyxambi\u003c\/strong\u003e offers a powerful, dual-action approach to managing Type 2 diabetes by combining the benefits of empagliflozin and linagliptin in a single, convenient tablet. With robust clinical data supporting its efficacy in improving glycemic control and reducing cardiovascular and renal risks, Glyxambi is a compelling option for patients who require comprehensive diabetes management. As always, consult your healthcare provider to determine if Glyxambi is the right treatment for your individual health needs.\u003c\/p\u003e\r\n\u003cp\u003e\u003cem\u003eDisclaimer: This information is provided for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider before starting or modifying any treatment regimen.\u003c\/em\u003e\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735740547355,"sku":"Glyxambi (Empagliflozin and Linagliptin) 25\/5mg 30 Tablets","price":85.2,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0992\/3303\/8619\/files\/glyxambi-25-5-fixed-dose-combination-of-empagliflozin-tablets.jpg?v=1770408080","url":"https:\/\/ezchemist.com\/products\/glyxambi-25-5mg","provider":"EZ Chemist","version":"1.0","type":"link"}